IDEXX Laboratories stock heads into the open after a 0.34% dip

At the close on September 11, 2026, IDEXX Laboratories stock finished at USD 504.88 on the Nasdaq, down 0.34%. The shares touched an intraday low near a new 52-week trough and traded over 7.6 million shares as the broader US market advanced.

IDEXX Laboratories stock closed at USD 504.88 on the Nasdaq on September 11, 2026, slipping 0.34% from the prior session. The move contrasted with gains in major US indices that day, underscoring relative weakness in the shares.

September 11, 2026 in numbers

IDEXX Laboratories Inc. (ISIN US45168D1046, Nasdaq: IDXX) ended the September 11, 2026 session at USD 504.88 after trading between an intraday high of USD 513.18 and a low of USD 501.00, according to S&P 500 component data from Cinco Dias. Volume reached about 7.6 million shares, markedly above typical recent turnover and leaving the company with a market value near USD 39.8 billion as indicated by the same overview. The quote data also show the stock roughly 25 percent below its 12-month high, highlighting a pronounced pullback over the past year.

On September 11, 2026 the broader US equity market advanced, with the Dow Jones Industrial Average rising 0.98 percent, the S&P 500 adding 0.86 percent and the Nasdaq Composite up 0.96 percent, per coverage from Sohu. Against that backdrop, IDEXX Laboratories lagged the major benchmarks, as the modest decline in its share price came while indices climbed. A technical signal overview from wallstreetONLINE flagged the stock as hitting a new 52-week low at around USD 502 on September 11, 2026, reinforcing the impression of sustained selling pressure into the close.

Today's focus for IDEXX Laboratories

As investors head into today's US session on September 14, 2026, no company-specific events such as an earnings release or annual meeting are listed for IDEXX Laboratories in the earnings calendar published by Yahoo Finance for today or the next few trading days. Broader market developments are likely to matter for the shares after Friday's underperformance, particularly any shifts in expectations around US monetary policy ahead of upcoming Federal Reserve decisions, as highlighted in macro commentary from El Toro Market Insights. With IDEXX Laboratories trading near a fresh 52-week low and the broader indices recently firm, the next session will show whether buyers begin to test support around the USD 500 area or whether the stock continues to trail the main benchmarks.